top of page

H7 Accelerator

Applications for 2025 Cohort are Open Now!

ABOUT H7 ACCELERATOR

H7 BioCapital offers a Once-a-Year virtual accelerator program specifically designed for healthcare companies from Seed to Series A stages. This 3-months long, equity free program features two specialized tracks: Life Science and Medtech, providing a unique opportunity to immerse in Silicon Valley and achieve strategic business objectives.​

With most of the portfolios either nearing the closure of their seed round funding, or preparing for their Series A round, this program focus primarily on fundraising and partnership opportunities. Throughout the program, companies will engage in weekly one-on-one meetings with investors mentors from our extensive network of 100+ advisors. They will also pitch both in-person and virtually during Demo Day and other conference organized by H7 and our network partners. 

​Additionally, the Life Science track emphasizes pre-clinical and clinical development plans and licensing-out opportunities, while the Medtech track concentrates on commercializing or expanding in the U.S. market. 

HIGHLIGHTS

Exceptional Quality

100+ Mentors

One-on-one mentor meetings

80+
VCs

Partnering with H7 Accelerator

Fund Raisings

Primary Focus of the Program

12+
Weeks

Virtual program

12+

Workshops

Customized to Cohorts

Free

Consultation

Tax, legal, FDA regulation, AWS credits

OUR ADVISOR NETWORK

One-on-one mentorship

Once you're selected for an accelerator cohort, you'll be part of the H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders.

Venture Capital
Clinical Trial
Marketing/Sales
CRO
Team Recruitment
Business Development
Manufacturing
FDA Regulations
Legal/Patent
Hospital Management
Clinician
Software Development
Finance
Science
Ella Li

Ella Li

Founding Partner

H7 BioCapital

Gary Goldman

Gary Goldman

Founding Partner

Global Health Impact Fund

Bill Reichert

Bill Reichert

General Partner

Pegasus Tech Ventures

Ted Hou

Ted Hou

Founding Partner

Berkeley Catalyst Fund

Stephan Pflanz

Stephan Pflanz

Executive Director

Boehringer-Ingelheim Venture Fund

Neil J. Littman

Neil J. Littman

Managing Director

Bioverge Ventures

logo.png

INDUSTRIAL FOCUS

Cutting-edge healthcare innovations

Life Science Track

Stage: Angel to Series A

We innovate within the biotech/biopharma sectors. Our focus areas include drug discovery, personalized medicine, synthetic biology, advanced drug delivery systems, and more. Join us in advancing these cutting-edge fields to revolutionize drug development and transform healthcare.

Medtech Track

Driving innovation in medical technology to enhance patient care and healthcare delivery. Our initiatives span across digital medicine, AI integration, cutting-edge medical devices

and digital health platforms aimed at enhancing clinical outcomes and optimizing healthcare processes.

Stage: Angel to Series A

2025 COHORT TIMELINE

Apply now

Applications Open

May 20th 

Early Bird Due

June 20th 

Applications Due

July 4th

Program Launch

September - December 2025

Demo Day Event

January 2026

Interview videos

PREVIOUS COHORT INTERVIEWS

Cutting-edge healthcare innovations

FAQS

  • Who can apply to H7 Healthcare Acceleration Program?
    H7 Healthcare Acceleration Program accepts applicants with breakthrough healthcare ideas & technologies: Startups in the stage from Seed to Series A; Industry: life science, biotech, digital medicine (MedTech), medical device, healthcare service; A team with original core technology; Clear direction of industry application.
  • What can you expect from H7Healthcare Accelerator Program?
    During the three-month program, startups will receive several key entrepreneurial resources including: Mentorship: One-on-one guidance from world-leading physicians, researchers, healthcare professionals and executives at least once a week. Workshop Trainings: Industry experts will lead 12 tailored workshops focusing on healthcare entrepreneurship. Clinician network: A large network of clinician advisors Funding Support: Initial capital injection opportunities provided by our global funding partners to the most promising companies of each cohort. Networks and Events: Networking events will be hosted regularly during each cohort. Teams can meet with our fund partners during Demo Day and Private Investor Meeting. International Growth: Join an international, mentor-filled ecosystem on Healthcare & Biotech Innovation. Alumni will gain direct access to our international partnerships in North America, Europe, and East Asia. Service: Access to Professional service teams including investment bankers, attorneys, auditors and CPAs etc. Continued support: from H7 to provide funding, commercialization, networking and other service after graduation Once you're selected for H7 accelerator cohort, you'll be part of the H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, advisors, and industry leaders.
  • How are applicants selected?
    Applicants are selected based on team dynamics, experience, and technology & product characteristics. Other factors include the business model, market strategy, potential market size, and total financial considerations. Applicants are evaluated through three screening rounds.
  • How much funding is offered?
    Each selected team receives mentorship, workshops, co-working space, and becomes a part of the huge network of H7 mentors, investors, healthcare entrepreneurs, global corporate partners. Initial capital injection opportunities are provided by our venture funding partners to the most promising companies of each cohort after the demo day. You will also gain the opportunity to get direct access to our business partners from healthcare corporates and financial investors.
  • Is there any kind of tuition cost for participating in H7 Healthcare Acceleration Program?
    Early bird applicants accepted into the program will be subject to a program fee of $7,490. This fee covers participation in events such as the H7 Healthcare Investment Forum, JPM Innovation Forum, Demo Day, H7 Private investor meetings, and partner events. H7 does not take any equity from accepted companies. For further inquiries, please contact us at info@h7biocapital.com.
  • Can startups participate without moving to the Bay Area?
    The program will be hybrid with an online presence, physical meet-ups and demo day events. we welcome applications from all over the world. However, we highly recommend you to participate in the program on-site, especially the demo day event. This benefits you because you can take advantage of the numerous opportunities, including the private investor meeting and networking. If you cannot move to the Bay Area for the program, workshops and mentor guidance are available online, but you may miss other benefits.
  • Will H7 sign a nondisclosure agreement?
    No, we do not sign nondisclosure agreements. No accelerator or venture firm would at this stage.
  • How do I apply for the H7 Healthcare Acceleration Program?
    If you are a startup entrepreneur, and want to join the program to boost your healthcare idea, please apply here: https://docs.google.com/forms/d/e/1FAIpQLSerdlW73eyp1A7rurH6w0heHnrLFDEen_CvHG5aqtBsXhTBuw/viewform If you a healthcare-relative mentor/advisor/investor/VC funds/corporate/organization/supplier, and want to become a H7 partner, please apply here: https://docs.google.com/forms/d/e/1FAIpQLSfzz7wnwC3J5XD1hML-LTTbHVmysMWtooFFE9DcTOYdUaZ0Sg/viewform
  • Do you have a list of the VC attendees that were at the last demo day?
    You will have a lot of opportunities to meet with investors during the cohort including the Demo Day. We don’t release a list of our investors, which is always changing. We make no promises, and success is a combination of our network and your hard work building your company.
FAQ

Subscribe to our news letter. Don't miss out!

Thanks for subscribing!

©2022 H7 BioCapital

All rights reserved.

bottom of page